The Susceptibility Prediction of Chemotherapy (FOLFIRI + Cetuximab Therapy) to Patients with Colorectal Cancer Liver Metastasis
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Sanghee Kang | - |
dc.date.accessioned | 2022-11-12T12:41:00Z | - |
dc.date.available | 2022-11-12T12:41:00Z | - |
dc.date.created | 2022-11-12 | - |
dc.date.issued | 2022-11-05 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/145176 | - |
dc.publisher | The Korean Surgical Society | - |
dc.title | The Susceptibility Prediction of Chemotherapy (FOLFIRI + Cetuximab Therapy) to Patients with Colorectal Cancer Liver Metastasis | - |
dc.title.alternative | The Susceptibility Prediction of Chemotherapy (FOLFIRI + Cetuximab Therapy) to Patients with Colorectal Cancer Liver Metastasis | - |
dc.type | Conference | - |
dc.contributor.affiliatedAuthor | Sanghee Kang | - |
dc.identifier.bibliographicCitation | Annual Congress of KSS 2022 & 74th Congress of the Korean Surgical Society | - |
dc.relation.isPartOf | Annual Congress of KSS 2022 & 74th Congress of the Korean Surgical Society | - |
dc.relation.isPartOf | ACKSS2022 | - |
dc.citation.title | Annual Congress of KSS 2022 & 74th Congress of the Korean Surgical Society | - |
dc.citation.conferencePlace | KO | - |
dc.citation.conferenceDate | 2022-11-03 | - |
dc.type.rims | CONF | - |
dc.description.journalClass | 1 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.